Assembly Biosciences (ASMB) CMO awarded 26,000 RSUs vesting through 2030

robot
Abstract generation in progress

Assembly Biosciences’ Chief Medical Officer, Anuj Gaggar, was granted 26,000 Restricted Stock Units (RSUs) as part of his annual equity compensation. These RSUs will vest in four equal installments annually from March 29, 2027, through March 29, 2030, provided he remains with the company. This grant represents 65% of his annual equity award, with the remaining 35% contingent on stockholder approval of an increase in shares authorized under the company’s 2018 stock incentive plan.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin